physcione has been researched along with usnic acid in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bucar, F; Ingólfsdóttir, K; Ogmundsdóttir, H; Schneider, I | 1 |
| Bačkor, M; Bačkorová, M; Fedoročko, P; Jendželovský, R; Mikeš, J | 1 |
| Backor, M; Brabec, V; Kasparkova, J; Kozurkova, M; Plsíkova, J; Stepankova, J | 1 |
| Ulus, G | 1 |
1 review(s) available for physcione and usnic acid
| Article | Year |
|---|---|
Antiangiogenic properties of lichen secondary metabolites.
Topics: Angiogenesis Inhibitors; Anti-Infective Agents; Benzofurans; Biological Products; Cyanobacteria; Emodin; Fungi; Furans; Humans; Lichens; Phenylacetates; Salicylates; Xanthones | 2021 |
3 other study(ies) available for physcione and usnic acid
| Article | Year |
|---|---|
Anti-proliferative lichen compounds with inhibitory activity on 12(S)-HETE production in human platelets.
Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; 4-Butyrolactone; Benzoates; Benzofurans; Blood Platelets; Depsides; Emodin; Humans; In Vitro Techniques; Lactones; Lichens; Lipoxygenase; Lipoxygenase Inhibitors; Molecular Structure; Resorcinols; Salicylates | 2004 |
Variable responses of different human cancer cells to the lichen compounds parietin, atranorin, usnic acid and gyrophoric acid.
Topics: Antineoplastic Agents; Apoptosis; Benzoates; Benzofurans; Cell Adhesion; Cell Line, Tumor; Cell Nucleus Shape; Cell Proliferation; Cell Survival; Drug Discovery; Drug Screening Assays, Antitumor; Emodin; Humans; Hydroxybenzoates; Lichens; Neoplasms; Osmolar Concentration; S Phase | 2011 |
Lichen secondary metabolites as DNA-interacting agents.
Topics: Animals; Benzoates; Benzofurans; Cattle; Circular Dichroism; DNA; Emodin; Humans; Hydroxybenzoates; Intercalating Agents; Kinetics; Lichens; Nucleic Acid Conformation; Spectrophotometry, Ultraviolet; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors | 2014 |